Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding IVBUF?
Track your performance easily
IVBUF Price & Analysis
IVBUF ETF Chart & Stats
Day’s Range― - ―
52-Week Range$5.38 - $7.09
Previous Close$7.09
VolumeN/A
Average Volume (3M)2.08K
AUM543.32M
NAV7.10
Expense Ratio0.35%
Holdings Count215
Beta0.26
Inception DateOct 19, 2017
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.06
10 Day Avg. Volume1,014
30 Day Avg. Volume2,080
Alpha0.00284
iShares NASDAQ US Biotechnology UCITS ETF (IVBUF) Fund Flow Chart
iShares NASDAQ US Biotechnology UCITS ETF (IVBUF) 1 year Net Flows: $71M
IVBUF ETF News
IVBUF ETF FAQ
What was IVBUF’s price range in the past 12 months?
IVBUF lowest ETF price was $5.38 and its highest was $7.09 in the past 12 months.
What is the AUM of IVBUF?
As of Sep 16, 2024 The AUM of IVBUF is 543.32M.
Is IVBUF overvalued?
According to Wall Street analysts IVBUF’s price is currently Undervalued.
Does IVBUF pay dividends?
IVBUF does not currently pay dividends.
How many shares outstanding does IVBUF have?
Currently, no data Available
Which hedge fund is a major shareholder of IVBUF?
Currently, no hedge funds are holding shares in IVBUF
IVBUF ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Gilead Sciences
9.31%
Regeneron Pharmaceuticals
8.47%
Amgen Inc
7.89%
Vertex Pharmaceuticals Inc.
7.74%
AstraZeneca
3.65%
Alnylam Pharmaceuticals
3.32%
Biogen Inc.
2.82%
Moderna
2.53%
Summit Therapeutics PLC
2.02%
Illumina
2.00%
Total49.75%
ETF Description
iShares NASDAQ US Biotechnology UCITS ETF
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.